Skip to content
The Kids Research Institute Australia logo

Short-Term Safety of Concomitant Meningococcal B and National Immunisation Program Vaccines in Infants Aged < 15 Months: A Survey-Based Surveillance Study

Citation:
Nguyen T, Tay ECS, Dymock M, Snelling TL, Dawes L, Marsh J, Wu Y, et al. Short-Term Safety of Concomitant Meningococcal B and National Immunisation Program Vaccines in Infants Aged < 15 Months: A Survey-Based Surveillance Study. Med J Aust. 2026;224(9).

Keywords:
Adverse drug reactions; childhood diseases; models; statistical; surveillance; vaccination; vaccine preventable disease

Abstract:
To examine short-term safety outcomes following vaccination at 2-, 4-, 6- and 12-month timepoints, comparing infants receiving meningococcal B vaccines concomitantly with National Immunisation Program vaccines to those receiving vaccines at separate visits.